Nanoviricides

NNVCNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$32.946 M

$1.29 -6.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Nanoviricides (NNVC) has a market capitalization of $32.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$9.47M

Loss-making

Shares outstanding

25,525,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#358Nasus PharmaNSRX$33.8M
#359ScynexisSCYX$33.1M
#360NanoviricidesNNVC$32.9M
#361ProMIS NeurosciencesPMN$31.7M
#362Rockwell MedicalRMTI$30.8M

What if Nanoviricides were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,105,618

Per share 857,069× higher

Bitcoin $1.53T

$59,823.09

Per share 46,374× higher

Apple $5.02T

$196,393.61

Per share 152,243× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Nanoviricides are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.